Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05471908
Other study ID # IHS-2021C1-22388
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 22, 2022
Est. completion date February 28, 2028

Study information

Verified date April 2024
Source University of Utah
Contact Eric Coon, MD, MS
Phone 801-587-2160
Email Eric.Coon@hsc.utah.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Compare the effectiveness of automatic vs as-needed (PRN) post-hospitalization follow-up for children who are hospitalized for common infections.


Description:

BACKGROUND: Automatic post-hospitalization follow-up visits are commonly recommended by hospital-based pediatricians. The intuitive appeal of automatic follow-up visits is that they might decrease hospital readmissions and promote continuity of care. However, automatic follow-up visits result in missed work for parents, missed school for children, and expenses like co-pays and transportation costs. The principal alternative strategy to automatic follow-up is PRN (pro re nata, "as-needed") follow-up, a patient and family-centered approach that empowers parents to monitor their child's symptoms and decide if a follow-up visit is necessary. OBJECTIVE: Compare the effectiveness of automatic vs as-needed (PRN) post-hospitalization follow-up for children who are hospitalized for common infections. DESIGN: The Follow-up Automatically vs As-Needed Comparison (FAAN-C, or "fancy") trial is a multicenter randomized controlled trial POPULATION: Children hospitalized for pneumonia, skin and soft tissue infection, acute gastroenteritis, or urinary tract infection will be eligible for enrollment. EXPERIMENTAL INTERVENTION: Randomization to a recommendation for PRN post-hospitalization follow-up CONTROL INTERVENTION: Randomization to a recommendation for automatic post-hospitalization follow-up OUTCOMES: The primary outcome is hospital readmission within 14 days of discharge. Secondary outcomes are medical interventions and child health-related quality of life. Exploratory outcomes are cost burden, child time, parent time, symptom duration, total additional ambulatory visits, non-primary care ambulatory visits, parent self-efficacy, parent anxiety, satisfaction with care, telephone and electronic communications with medical providers, well-child visits, immunizations, usual place of medical care, and medical interventions related to the index infection. Safety outcomes are medical errors and hospital readmissions related to the index infection. TRIAL SIZE: A total of 2,674 patients (1,337 patients in each group) will be randomized, providing 90% power to demonstrate non-inferiority of a recommendation for PRN follow-up compared to a recommendation for automatic follow-up.


Recruitment information / eligibility

Status Recruiting
Enrollment 2674
Est. completion date February 28, 2028
Est. primary completion date February 2027
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - Age <18 years at the time of randomization - Hospitalization due to a primary diagnosis of pneumonia, skin and soft tissue infection, acute gastroenteritis, or urinary tract infection. - Parent speaks English or Spanish. Exclusion Criteria: - Presence of a comorbid disease that is both chronic and complex - Principal disease required surgical intervention (beyond superficial incision and drainage) - Immunodeficiency - A well-child check-up or post-hospitalization follow-up visit is already scheduled within 7 days of hospital discharge - Parent or participant strongly prefers PRN or automatic follow-up - A medical provider feels strongly that a post-hospitalization follow-up visit is needed within 7 days of hospital discharge - Sibling concurrently hospitalized - Unable to identify a clinic where the participant would receive any needed post-hospitalization follow-up - Diagnosis of pneumonia complicated by: o Receiving a chest tube - Diagnosis of urinary tract infection complicated by: - History of neurogenic bladder or urologic surgery - Renal imaging anticipated within 7 days of hospital discharge - Renal abscess - Diagnosis of skin and soft tissue infection complicated by: - Chronic wound - Postoperative infection - Predisposition to poor wound healing - Discharging with a drain in place - Complicated by necrotizing fasciitis or toxic shock syndrome - Diagnosis of gastroenteritis complicated by: - Hemolytic uremic syndrome

Study Design


Intervention

Behavioral:
As-needed follow up
At hospital discharge, participant receives a recommendation for PRN follow-up. Recommendation informs participant that scheduling a follow-up visit is not needed at discharge and suggests that participant follow symptoms after discharge to decide if a visit is ultimately needed or not.
Automatic follow-up
At hospital discharge, participant receives a recommendation for automatic follow-up. Recommendation instructs participant to schedule a follow-up visit and attend the visit even if symptoms get better.

Locations

Country Name City State
United States Cincinnati Children's Hospital Medical Center - Main Campus Cincinnati Ohio
United States Texas Children's Main Houston Texas
United States Texas Children's West Houston Texas
United States Intermountain Primary Children's Hospital Larry H. and Gail Miller Family Campus Lehi Utah
United States Cincinnati Children's Hospital Medical Center - Liberty Campus Liberty Township Ohio
United States Packard at El Camino Hospital Mountain View California
United States Lucile Packard Children's Hospital Palo Alto California
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania
United States Phoenix Children's Hospital Phoenix Arizona
United States Penn Medicine Princeton Medical Center Plainsboro New Jersey
United States Riverton Hospital Riverton Utah
United States St. Louis Children's Hospital Saint Louis Missouri
United States Primary Children's Hospital Salt Lake City Utah

Sponsors (2)

Lead Sponsor Collaborator
University of Utah Patient-Centered Outcomes Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Cost burden Mean total costs to parents (missed income and expenses) related to the participant's illness within 14 days of hospital discharge, measured by the cost burden survey. Within 14 days of hospital discharge
Other Child time Mean number of hours of school or daycare missed by the participant within 14 days of hospital discharge as a result of their medical needs Within 14 days of hospital discharge
Other Parent time Mean number of hours spent away from responsibilities (work or non-work related) by parents within 14 days of hospital discharge as a result of their child's medical needs Within 14 days of hospital discharge
Other Symptom duration Proportion of participants who have completely recovered from their infection at 7 days after hospital discharge Within 7 days of hospital discharge
Other Total additional ambulatory visits Mean number of ambulatory visits (in-person or via telehealth) that a participant attends, apart from the post-hospitalization follow-up visit, within 30 days of hospital discharge; Ambulatory visits include clinic, urgent care, and emergency department (not resulting in hospital admission) visits. Within 30 days of hospital discharge
Other Non-primary care ambulatory visits Mean number of ambulatory visits (in-person or via telehealth) to non-primary care providers, within 30 days of hospital discharge; Non-primary care providers will include all providers outside of the clinic that families identify as their primary care clinic. Within 30 days of hospital discharge
Other Parent self-efficacy Mean self-efficacy score 7 days after hospital discharge, measured by the PROMIS self-efficacy short form. 7 days after hospital discharge
Other Parent anxiety Mean anxiety score 7 days after hospital discharge, measured by the PROMIS anxiety short form. 7 days after hospital discharge
Other Satisfaction with care Proportion of participants who report agreeing or strongly agreeing with the statement, "I am satisfied with the medical care my child has received since hospital discharge," 7 days after hospital discharge 7 days after hospital discharge
Other Telephone and electronic communications with medical providers Mean number of telephone and electronic (excluding telehealth visits) communications with a medical provider within 14 days of hospital discharge Within 14 days of hospital discharge
Other Well-child visits Proportion of participants who attend a well-child visit within Proportion of participants who attend a well-child visit within 6 months of hospital discharge Within 6 months of hospital discharge
Other Immunizations Proportion of participants who receive an immunization within 6 months of hospital discharge Within 6 months of hospital discharge
Other Usual place of medical care Proportion of participants who report having a usual place of medical care 6 months after hospital discharge Within 6 months of hospital discharge
Other Medical interventions related to the index infection Proportion of participants who receive either a laboratory test, imaging test, or a new medication related to the index infection within 14 days of hospital discharge Within 14 days of hospital discharge
Other Medical errors Proportion of parents who report that their child experienced a medical error within 14 days of hospital discharge, measured by the Family Safety Interview Within 14 days of hospital discharge
Other Hospital readmissions related to the index infection Proportion of participants who experience a hospital readmission related to the index infection within 14 days of hospital discharge Within 14 days of hospital discharge
Primary Hospital readmission The proportion of participants who experience a hospital readmission within 14 days of their index hospital discharge. Within 14 days of hospital discharge
Secondary Medical interventions The proportion of participants who receive either a laboratory test, imaging test, or a new medication within 14 days of hospital discharge Within 14 days of hospital discharge
Secondary Child health-related quality of life Mean health-related quality of life score 7 days after hospital discharge, measured by the Impact on Activities and Routines instrument. 7 days after hospital discharge
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04244474 - Effect of Vitamin D Supplementation on Improvement of Pneumonic Children Phase 1/Phase 2
Completed NCT05815264 - Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above Phase 1
Recruiting NCT04589936 - Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care N/A
Completed NCT02905383 - The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital N/A
Completed NCT06210737 - A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months,7 Months-5 Years Phase 4
Terminated NCT03944551 - Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa N/A
Terminated NCT04660084 - Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT05702788 - Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19) Phase 2
Not yet recruiting NCT04171674 - Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation. N/A
Active, not recruiting NCT03140163 - Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR] N/A
Completed NCT02638649 - Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
Completed NCT02864420 - Hospitalization at Home: The Acute Care Home Hospital Program for Adults N/A
Recruiting NCT02515565 - Physiotherapy in Patients Hospitalized Due to Pneumonia. N/A
Completed NCT02105298 - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study) N/A
Completed NCT01446926 - Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants Phase 1
Completed NCT01416519 - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation N/A
Completed NCT01399723 - Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia Phase 3
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Terminated NCT02358642 - Drug to Prevent Pneumonia in the Tube Fed Phase 4